Skip to content

Commit

Permalink
醋酸甲羟孕酮:青春期抑制用
Browse files Browse the repository at this point in the history
Signed-off-by: Mingye Wang <arthur200126@gmail.com>
  • Loading branch information
Artoria2e5 authored Jan 18, 2025
1 parent 8475c7f commit e57aa53
Showing 1 changed file with 5 additions and 1 deletion.
Original file line number Diff line number Diff line change
Expand Up @@ -10,6 +10,8 @@ description: 醋酸甲羟孕酮(Medroxyprogesterone Acetate),是一种类
醋酸甲羟孕酮(Medroxyprogesterone Acetate, MPA),是一种类固醇孕激素,具有抗促性腺激素作用,可以抑制体内雄激素水平。[^1] 在无法获取到 [醋酸环丙孕酮(色谱龙)]({{< ref cyproterone >}}) 时可作为替代品服用,但效果稍差。[^2] [^3] [^11]
关于 MPA 对睾酮水平的抑制作用,可参考[下文]({{< ref "#testosterone-suppression" >}})。

除作为 MtF HRT 的一部分抑制雄激素水平外,也可用于未成年人的青春期阻断治疗,相比 GnRH 类似物价格更低廉。[^14]旧时也用于治疗早发育,但由于不能抑制早发育对骨的影响,现已被 GnRH 类似物替代。[^15]用于青春期阻断无此考虑。

> **大中华区上市状况**
```csv
Expand Down Expand Up @@ -86,4 +88,6 @@ description: 醋酸甲羟孕酮(Medroxyprogesterone Acetate),是一种类
[^10]: 嘉義基督教醫院. 藥品詳細資訊:Medrone 5mg Tablets [EB/OL]. \[[資訊頁](https://www.cych.org.tw/pharm/searchdrugdetail.aspx?drug_serial=9622)] \[[仿單](https://www.cych.org.tw/pharm/%e4%bb%bf%e5%96%ae/PROVE-1080726.pdf)]
[^11]: Aly. An Introduction to Hormone Therapy for Transfeminine People [EB/OL]. *Transfeminine Science*, 2018. 译文:《[女性倾向跨性别者的激素治疗简介](https://tfsci.mtf.wiki/articles/transfem-intro/)
[^12]: Meyer W J, Walker P A, Emory L E, et al. Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate [J]. *Fertility and Sterility*, 1985, 43(1): 102-109. DOI: [10.1016/S0015-0282(16)48326-3](https://www.sciencedirect.com/science/article/pii/S0015028216483263)
[^13]: Pfizer. Prescribing Information: PROVERA&reg; [EB/OL]. Drugs@FDA, 2024. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011839s083lbl.pdf>[译文](https://tfsci.mtf.wiki/misc/provera/)
[^13]: Pfizer. Prescribing Information: PROVERA&reg; [EB/OL]. Drugs@FDA, 2024. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/011839s083lbl.pdf>[译文](https://tfsci.mtf.wiki/misc/provera/)
[^14]: Jain J, Kwan D, Forcier M. Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. J Clin Endocrinol Metab. 2019 Nov 1;104(11):5148-5156. doi: [10.1210/jc.2018-02253](https://academic.oup.com/jcem/article/104/11/5148/5479358). PMID: 31127826.
[^15]: Wheeler MD, Styne DM. Diagnosis and management of precocious puberty. Pediatr Clin North Am. 1990 Dec;37(6):1255-71. doi: 10.1016/s0031-3955(16)37010-9. PMID: 2147987.

0 comments on commit e57aa53

Please sign in to comment.